All In Biotech

Free tool

FAERS Monitor: Creon

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 020725 or its brand name (Creon, Pancrelipase (Amylase, Lipase, Protease)). Reports on generic versions are filed under their own applications.

Reports

38,797

Serious

28,976

75% of reports

Hospitalization

14,677

Death reported

3,888

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea3,834
  • death2,040
  • nausea1,890
  • weight decreased1,856
  • fatigue1,660
  • abdominal pain1,572
  • vomiting1,475
  • pain1,338
  • abdominal pain upper1,311
  • pancreatic carcinoma1,295
  • infective pulmonary exacerbation of cystic fibrosis1,238
  • drug ineffective1,209
  • malaise1,189
  • dyspnoea1,188
  • off label use1,170

Reports by year received

View as table
YearReports
2004105
200594
200699
200786
2008127
2009191
2010290
2011380
2012498
2013686
2014958
20151,365
20161,772
20171,795
20182,451
20193,620
20203,401
20212,446
20222,749
20232,591
20243,627
20255,350
20264,115

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,015,362 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infective pulmonary exacerbation of cystic fibrosisSignal1,238159.3149.6150,394
pancreatic carcinomaSignal1,29525.424.029,014
abdominal painSignal1,5723.73.53,081
weight decreasedSignal1,8563.63.53,543
abdominal pain upperSignal1,3113.53.32,308
diarrhoeaSignal3,8343.23.16,063
vomiting1,4751.71.6436
malaise1,1891.51.4182
nausea1,8901.31.2132
death2,0401.31.2133
pain1,3381.21.138
fatigue1,6601.21.136
dyspnoea1,1881.11.120
off label use1,1700.70.7128
drug ineffective1,2090.50.5656

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.